Sarah Cannon Research Institute Denver — Denver, Colorado

Sarah Cannon Research Institute Denver is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute Denver has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC.

Sponsors: Tango Therapeutics, Inc., Pierre Fabre Medicament.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute Denver?

Sarah Cannon Research Institute Denver has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute Denver conducted?

Sarah Cannon Research Institute Denver has 2 clinical trials on record, with 2 currently active. Their work covers PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC.

Is Sarah Cannon Research Institute Denver accredited by Crixeo Health?

Sarah Cannon Research Institute Denver has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute Denver?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.